Novo begins study to find lowest effective dose for Wegovy pill
Novo Nordisk (NVO) begins a study to identify the lowest effective dose for a Wegovy pill formulation, according to Reuters coverage cited by Hammerstone MarketTalk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.